Proteomic Profiling of Breast Cancer Patient-Derived Xenograft

ABSTRACT: Mass spectrometry profiling of orthotopically transplanted breast cancer patient-derived xenograft (PDX) tumors prior to chemotherapy treatment.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

DISEASE(S): Breast Cancer

SUBMITTER: Ramakrishnan Rajaram Srinivasan  

LAB HEAD: Michael T. Lewis

PROVIDER: PXD035857 | Pride | 2022-12-06

REPOSITORIES: Pride